Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cinderella A. Fahmy, Amira M. Gamal-Eldeen, Enas A. El-Hussieny, Bassem M. Raafat, Nayra S. Mehanna, Roba M. Talaat & Mohamed T. Shaaban. (2019) Bifidobacterium longum Suppresses Murine Colorectal Cancer through the Modulation of oncomiRs and Tumor Suppressor miRNAs. Nutrition and Cancer 71:4, pages 688-700.
Read now
Read now
Sofia D. Nyberg, Monica Österblad, Antti J. Hakanen, Sonja Löfmark, Charlotta Edlund, Pentti Huovinen & Jari Jalava. (2007) Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin. Scandinavian Journal of Infectious Diseases 39:6-7, pages 514-520.
Read now
Read now
Lynne V. Mcfarland. (2000) A Review of the Evidence of Health Claims for Biotherapeutic Agents. Microbial Ecology in Health and Disease 12:2, pages 65-76.
Read now
Read now
E. Bertazzoni Minelli, A. Benini, L. Vicentini, E. Andreoli, M. Oselladore & R. Cerutti. (1996) Effect of Lactobacillus acidophilus and Bifidobacterium bifidum Administration on Colonic Microbiota and its Metabolic Activity in Premenstrual Syndrome. Microbial Ecology in Health and Disease 9:6, pages 247-260.
Read now
Read now
Articles from other publishers (64)
Rekha Kumari, Yasha Yadav, Richa Misra, Utpal Das, Upasana Das Adhikari, Pushkar Malakar & Gyanendra P. Dubey. (2022) Emerging frontiers of antibiotics use and their impacts on the human gut microbiome. Microbiological Research 263, pages 127127.
Crossref
Crossref
Manoj Kumar Yadav, Indu Kumari, Bijender Singh, Krishna Kant Sharma & Santosh Kumar Tiwari. (2022) Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Applied Microbiology and Biotechnology 106:2, pages 505-521.
Crossref
Crossref
Louise Kristine Vigsnaes, Jonas Ghyselinck, Pieter Van den Abbeele, Bruce McConnell, Frédéric Moens, Massimo Marzorati & Danica Bajic. (2021) 2′FL and LNnT Exert Antipathogenic Effects against C. difficile ATCC 9689 In Vitro, Coinciding with Increased Levels of Bifidobacteriaceae and/or Secondary Bile Acids. Pathogens 10:8, pages 927.
Crossref
Crossref
Hend Altaib, Yassien Badr & Tohru Suzuki. (2021) Bifidobacteria and Psychobiotic Therapy: Current Evidence and Future Prospects. Reviews in Agricultural Science 9:0, pages 74-91.
Crossref
Crossref
Khalid Muzaffar, Romee Jan, Naseer Ahmad Bhat, Adil Gani & Mudasir Ahmed Shagoo. 2021. Advances in Probiotics. Advances in Probiotics
417
435
.
Savitri & Prem Lata. 2021. Advances in Probiotics for Sustainable Food and Medicine. Advances in Probiotics for Sustainable Food and Medicine
181
212
.
Meghana Ajay Deshpande, Sudhindra Baliga, Sapna Randad, Nilima Thosar & Nilesh Rathi. (2020) Probiotic Bacteriotherapy and Its Oral Health Perspective. Journal of Evolution of Medical and Dental Sciences 9:34, pages 2479-2483.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2020) Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review. Archives of Disease in Childhood - Fetal and Neonatal Edition 105:2, pages 201-208.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2019) The effect of antibiotics on the composition of the intestinal microbiota - a systematic review. Journal of Infection 79:6, pages 471-489.
Crossref
Crossref
Jacob J. Patz, Melissa C. Helm, Rana M. Higgins, Matthew I. Goldblatt, Jon C. Gould & Tammy L. Kindel. (2019) Peri-operative, intravenous clindamycin may improve the resolution rate of hypertension after Roux-en-Y gastric bypass in morbidly obese patients. Surgical Endoscopy 33:12, pages 3984-3989.
Crossref
Crossref
Olesya Volokh, Natalia Klimenko, Yulia Berezhnaya, Alexander Tyakht, Polina Nesterova, Anna Popenko & Dmitry Alexeev. (2019) Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers. Nutrients 11:3, pages 547.
Crossref
Crossref
Danfeng Dong, Qi Ni, Chen Wang, Lihua Zhang, Zhen Li, Cen Jiang, EnqiangMao & Yibing Peng. (2018) Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China. BMC Infectious Diseases 18:1.
Crossref
Crossref
Muhammad Issa Khan, Cheorun Jo & Ubaid‐ur‐Rahman. 2017. Emerging Technologies in Meat Processing. Emerging Technologies in Meat Processing
285
319
.
Merlin W. Ariefdjohan, Abby Dilk, Onikia N. Brown-Esters & Dennis A. Savaiano. 2017. Nutrition in the Prevention and Treatment of Disease. Nutrition in the Prevention and Treatment of Disease
811
834
.
T. S. Swapna, A. S. Ninawe & Sabu Abdulhameed. 2017. Bioresources and Bioprocess in Biotechnology. Bioresources and Bioprocess in Biotechnology
383
406
.
Sadegh Jafarnejad, Sakineh Shab‐Bidar, John R. Speakman, Karim Parastui, Milad Daneshi‐Maskooni & Kurosh Djafarian. (2016) Probiotics Reduce the Risk of Antibiotic‐Associated Diarrhea in Adults (18–64 Years) but Not the Elderly (>65 Years). Nutrition in Clinical Practice 31:4, pages 502-513.
Crossref
Crossref
Caroline Vincent & Amee Manges. (2015) Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection. Antibiotics 4:3, pages 230-253.
Crossref
Crossref
L. V. McFarland. (2014) Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 4:8, pages e005047-e005047.
Crossref
Crossref
Hanan A. El-Bakry, Wafaa M. Zahran, Shaimaa A. Anter & Ahmed S. Zahran. (2013) Role of some selected Bifidobacterium strains in modulating immunosenescence of aged albino rats. The Journal of Basic & Applied Zoology 66:5, pages 255-262.
Crossref
Crossref
Borja Sánchez, Lorena Ruiz, Miguel Gueimonde, Patricia Ruas-Madiedo & Abelardo Margolles. (2013) Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences. Pharmacological Research 69:1, pages 127-136.
Crossref
Crossref
Merlin W. Ariefdjohan, Onikia N. Brown-Esters & Dennis A. Savaiano. 2013. Nutrition in the Prevention and Treatment of Disease. Nutrition in the Prevention and Treatment of Disease
719
738
.
E. J. Videlock & F. Cremonini. (2012) Meta‐analysis: probiotics in antibiotic‐associated diarrhoea. Alimentary Pharmacology & Therapeutics 35:12, pages 1355-1369.
Crossref
Crossref
Marina L. Ritchie & Tamara N. Romanuk. (2012) A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE 7:4, pages e34938.
Crossref
Crossref
Ashima Vohra & T. Satyanarayana. 2012. Microorganisms in Sustainable Agriculture and Biotechnology. Microorganisms in Sustainable Agriculture and Biotechnology
411
433
.
Mario Guslandi. 2010. Nutritional Management of Digestive Disorders. Nutritional Management of Digestive Disorders
149
157
.
Gemma E. Walton, Ying Ni Lim, Yong Kwan Ng, Ravi Hannah & Kirsty Hunter. (2010) Prebiotics and probiotics: potential strategies for reducing travellers' diarrhoea in athletes competing abroad. Food Science & Technology Bulletin: Functional Foods 6:9, pages 105-114.
Crossref
Crossref
Christina M. Surawicz. 2009. Prebiotics and Probiotics Science and Technology. Prebiotics and Probiotics Science and Technology
825
843
.
Camilla Hoppe, Charlotte Nexmann Larsen, Rangne Fondén, Ulla Svensson, Arthur Ouwehand, Sampo Lahtinen, Mayumi Kiwaki, Koji Nomoto, Katsunori Kimura, Dorte Eskesen, Maija Saxelin, Kajsa Kajander, Gregor Reid, Andrew W. Bruce, Päivi Nurminen, Riitta Korpela, Hirokazu Tsuji, Jin‐Zhong Xiao & Seppo Salminen. 2008. Handbook of Probiotics and Prebiotics. Handbook of Probiotics and Prebiotics
441
532
.
M. Carmen Collado, J.M. Laparra, Rafael Frias, Yuan Kun Lee, Seppo Salminen, Allan Lim & Hai‐Meng Tan. 2008. Handbook of Probiotics and Prebiotics. Handbook of Probiotics and Prebiotics
257
375
.
Christina M. Surawicz. (2008) Role of Probiotics in Antibiotic-associated Diarrhea, Clostridium difficile-associated Diarrhea, and Recurrent Clostridium difficile-associated Diarrhea. Journal of Clinical Gastroenterology 42:Supplement 2, pages S64-S70.
Crossref
Crossref
Ahmad Cheikhyoussef, Natascha Pogori, Wei Chen & Hao Zhang. (2008) Antimicrobial proteinaceous compounds obtained from bifidobacteria: From production to their application. International Journal of Food Microbiology 125:3, pages 215-222.
Crossref
Crossref
Carolyn Eddins & Mikel Gray. (2008) Are Probiotic or Synbiotic Preparations Effective for the Management of Clostridium Difficile-Associated or Radiation-Induced Diarrhea?. Journal of Wound, Ostomy & Continence Nursing 35:1, pages 50-58.
Crossref
Crossref
E. KheadrN. DabourU. von AhC. LacroixL. MeileI. Fliss. (2007) Genetic and phenotypic diversity of Bifidobacterium thermacidophilum fecal isolates from newborns. Canadian Journal of Microbiology 53:12, pages 1348-1359.
Crossref
Crossref
Åsa Sullivan & Carl Nord. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology
335
369
.
S. Parvez, K.A. Malik, S. Ah Kang & H.-Y. Kim. (2006) Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 100:6, pages 1171-1185.
Crossref
Crossref
Elizabeth S. Huebner & Christina M. Surawicz. (2006) Probiotics in the Prevention and Treatment of Gastrointestinal Infections. Gastroenterology Clinics of North America 35:2, pages 355-365.
Crossref
Crossref
Sunil Sazawal, Girish Hiremath, Usha Dhingra, Pooja Malik, Saikat Deb & Robert E Black. (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases 6:6, pages 374-382.
Crossref
Crossref
Lynne V McFarland. (2006) Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease. The American Journal of Gastroenterology 101:4, pages 812-822.
Crossref
Crossref
G. A. O'May & G. T. Macfarlane. 2006. Probiotic Dairy Products. Probiotic Dairy Products
138
166
.
Bruno Biavati & Paola Mattarelli. 2006. The Prokaryotes. The Prokaryotes
322
382
.
S.C. Leahy, D.G. Higgins, G.F. Fitzgerald & D. Sinderen. (2005) Getting better with bifidobacteria. Journal of Applied Microbiology 98:6, pages 1303-1315.
Crossref
Crossref
Cecilia Jernberg, Åsa Sullivan, Charlotta Edlund & Janet K. Jansson. (2005) Monitoring of Antibiotic-Induced Alterations in the Human Intestinal Microflora and Detection of Probiotic Strains by Use of Terminal Restriction Fragment Length Polymorphism. Applied and Environmental Microbiology 71:1, pages 501-506.
Crossref
Crossref
E. Kheadr, N. Bernoussi, C. Lacroix & I. Fliss. (2004) Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. International Dairy Journal 14:12, pages 1041-1053.
Crossref
Crossref
Oskar Adolfsson, Simin Nikbin Meydani & Robert M Russell. (2004) Yogurt and gut function. The American Journal of Clinical Nutrition 80:2, pages 245-256.
Crossref
Crossref
R. Toure, E. Kheadr, C. Lacroix, O. Moroni & I. Fliss. (2003) Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. Journal of Applied Microbiology 95:5, pages 1058-1069.
Crossref
Crossref
Harsharnjit S Gill. (2003) Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Practice & Research Clinical Gastroenterology 17:5, pages 755-773.
Crossref
Crossref
Christina M Surawicz. (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Practice & Research Clinical Gastroenterology 17:5, pages 775-783.
Crossref
Crossref
Kieran M Tuohy, Hollie M Probert, Chris W Smejkal & Glann R Gibson. (2003) Using probiotics and prebiotics to improve gut health. Drug Discovery Today 8:15, pages 692-700.
Crossref
Crossref
F. Cremonini, S. Di Caro, L. Santarelli, M. Gabrielli, M. Candelli, E.C. Nista, A. Lupascu, G. Gasbarrini & A. Gasbarrini. (2002) Probiotics in antibiotic-associated diarrhoea. Digestive and Liver Disease 34, pages S78-S80.
Crossref
Crossref
Colum Dunne & Fergus Shanahan. (2002) Role of probiotics in the treatment of intestinal infections and inflammation. Current Opinion in Gastroenterology 18:1, pages 40-45.
Crossref
Crossref
Åsa Sullivan, Charlotta Edlund & Carl Erik Nord. (2001) Effect of antimicrobial agents on the ecological balance of human microflora. The Lancet Infectious Diseases 1:2, pages 101-114.
Crossref
Crossref
Gary W. Elmer & Lynne V. McFarland. (2001) BIOTHERAPEUTIC AGENTS IN THE TREATMENT OF INFECTIOUS DIARRHEA. Gastroenterology Clinics of North America 30:3, pages 837-854.
Crossref
Crossref
Colum Dunne. (2001) Adaptation of Bacteria to the Intestinal Niche: Probiotics and Gut Disorder. Inflammatory Bowel Diseases 7:2, pages 136-145.
Crossref
Crossref
Giuseppe Zoppi, Mauro Cinquetti, Anna Benini, Elettra Bonamini & Elisa Bertazzoni Minelli. (2001) Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. Current Therapeutic Research 62:5, pages 418-435.
Crossref
Crossref
Philippe R Marteau, Michael de Vrese, Christophe J Cellier & Jürgen Schrezenmeir. (2001) Protection from gastrointestinal diseases with the use of probiotics. The American Journal of Clinical Nutrition 73:2, pages 430s-436s.
Crossref
Crossref
Lori Kopp-Hoolihan. (2001) Prophylactic and Therapeutic Uses of Probiotics. Journal of the American Dietetic Association 101:2, pages 229-241.
Crossref
Crossref
K. Orrhage, S. Sjostedt & C. E. Nord. (2000) Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. Journal of Antimicrobial Chemotherapy 46:4, pages 603-612.
Crossref
Crossref
Elmer, McFarland, Surawicz, Danko & Greenberg. (2001)
Behaviour of
Saccharomyces boulardii
in recurrent
Clostridium difficile
disease patients
. Alimentary Pharmacology & Therapeutics 13:12, pages 1663-1668.
Crossref
Crossref
Lynne V. McFarland. (1999) Microecologic approaches for traveler’s diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea. Current Gastroenterology Reports 1:4, pages 301-307.
Crossref
Crossref
Irène Mangin, Yoram Bouhnik, Nathalie Bisetti & Bernard Decaris. (1999) Molecular monitoring of human intestinal Bifidobacterium strain diversity. Research in Microbiology 150:5, pages 343-350.
Crossref
Crossref
Kerstin Orrhage & Carl Erik Nord. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases
85
120
.
Steven W. Martin, Anne C. Heatherington & Gary W. Elmer. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases
47
84
.
Roy Fuller & Glenn R. Gibson. (1998) Probiotics and prebiotics: microflora management for improved gut health. Clinical Microbiology and Infection 4:9, pages 477-480.
Crossref
Crossref
Carl Erik Nord, Ann Lidbeck, Kerstin Orrhage & Svante Sjöstedt. (1997) Oral supplementation with lactic acid-producing bacteria during intake of clindamycin. Clinical Microbiology and Infection 3:1, pages 124-132.
Crossref
Crossref